Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations

Dihydroergotamine (DHE) is an ergot alkaloid derivative of substances produced by rye fungus. Ergotamine was first used in the field of gynecology and obstetrics, then used for migraine treatment a few years later. DHE was developed as a derivative of ergotamine. DHE, when compared to ergotamine, de...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafqat, Rafia, Flores-Montanez, Yadira, Delbono, Victoria, Nahas, Stephanie J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200221/
https://www.ncbi.nlm.nih.gov/pubmed/32431533
http://dx.doi.org/10.2147/JPR.S203650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200221/
https://www.ncbi.nlm.nih.gov/pubmed/32431533
http://dx.doi.org/10.2147/JPR.S203650

Ejemplares similares